Onvansertib: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Onvansertib

• Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
  NCT06736717 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
  NCT05450965 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Targeted Pathway Inhibition in Patients With Pancreatic Cancer
  NCT04005690 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Onvansertib?

3 recruiting trials across 12 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.